How effective is natalizumab as second-line treatment for multiple sclerosis in daily clinical praxis?

2 Citations (Scopus)

Abstract

Udgivelsesdato: 2009/3

Original language	English
Journal	European Journal of Neurology
Volume	16
Issue number	3
Pages (from-to)	287-288
Number of pages	1
ISSN	1351-5101
Publication status	Published - 2009

@article{83538d405c0f11df928f000ea68e967b,

title = "How effective is natalizumab as second-line treatment for multiple sclerosis in daily clinical praxis?",

abstract = "Udgivelsesdato: 2009/3",

author = "S{\o}rensen, {Per Soelberg}",

year = "2009",

language = "English",

volume = "16",

pages = "287--288",

journal = "European Journal of Neurology",

issn = "1351-5101",

publisher = "Wiley-Blackwell",

number = "3",

}